Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2007 | Intravenous saline injection (Placebo) Wiki | 1.00 |
| drug1960 | Interferon Beta-1B Wiki | 0.58 |
| drug3361 | Ribavirin Wiki | 0.50 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D007239 | Infection NIH | 0.05 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This clinical trial is set out to evaluate the safety and efficacy of allogeneic human dental pulp mesenchymal stem cells in the treatment of severe pneumonia caused by COVID-19; to explore the effects of human dental pulp mesenchymal stem cells in the treatment of severe pneumonia of COVID-19 in terms of reducing mortality and improving clinical prognosis; and to discover a new therapeutic strategy for COVID-19 using allogeneic human dental pulp mesenchymal stem cells.
Description: Time to Clinical Improvement
Measure: TTCI Time: 1-28 daysDescription: Lung Lesion by CT
Measure: Lung lesion Time: 1-28 daysDescription: Th1 cytokines: IL-1β, IL- 2, TNF-a, ITN-γ; Th2 cytokines: IL- 4, IL- 6, IL- 10; Immunoglobulins: IgA, IgG, IgM, and total IgE; Lymphocyte counts: CD3+, CD4+, CD8+, CD16+,CD19+, CD56+.
Measure: Immune function Time: 1-28 daysDescription: Time of SARS-CoV-2 test turns negative
Measure: Time of SARS-CoV-2 clearance Time: 1-28 daysDescription: Blood cell count and classification
Measure: Blood test Time: 1-28 daysDescription: Pulse oximetry
Measure: SPO2 Time: 1-28 daysDescription: Respiratory rate
Measure: RR Time: 1-28 daysDescription: Body temperature
Measure: Body temperature Time: 1-28 daysDescription: Number of the included patients with hDPSCs-related adverse events, e.g. liver or kidney function failure
Measure: Side effects in the treatment group Time: 1-28 daysDescription: C-reactive protein in microgram per litre
Measure: C-reactive protein (mg/L) Time: 1-28 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports